Most Read Articles
Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Tristan Manalac, 11 Jan 2019
Less than 15 percent of Singaporean adolescents get the recommended 8–10 hours of sleep on a school night, reports a recent study, noting that such short sleep duration is linked to symptoms of depression, overweight or obesity, and poorer self-rated health.
04 Jan 2019
Obstructive sleep apnoea may increase the risk of male-pattern baldness in men with a family history of hair loss, and this association appears to be mediated by low serum transferrin saturation levels related to hypoxia, a study suggests.
6 days ago
Airway type 2 inflammation remains persistent in many asthmatics on inhaled corticosteroids, a new study has shown. These patients tend to be older and have a more severe disease.

TAVR safer than SAVR in terms of bleeding, acute kidney injury, atrial fibrillation

26 Apr 2018
In intermediate risk patients, the TAVR is found to have better outcomes

Transcatheter aortic valve replacement (TAVR) in severe symptomatic aortic stenosis (AS) patients is superior to conventional surgical aortic valve replacement (SAVR) in terms of reducing life-threatening bleeding, new-onset atrial fibrillation and acute kidney injury, a recent meta-analysis has found.

Pooled analysis of four studies (n=4,355; TAVR: n=2,222) showed that, at 2-year follow-up, TAVR was associated with a significantly lower rate of life-threatening bleeding (risk ratio [RR], 0.45; 95 percent CI, 0.28–0.73; p=0.001), acute kidney injury (RR, 0.48; 0.25–0.93; p=0.03) and new atrial fibrillation (RR, 0.46; 0.33–0.64; p<0.0001).

In contrast, TAVR was inferior to SAVR in terms of permanent pacemaker implantation (RR, 3.01; 1.04–8.72; p=0.04) and aortic-valve reintervention (RR, 3.22; 1.64–6.29; p=0.0006), both of which were significantly more frequent in TAVR patients.

There were no significant differences between the two treatments in terms of deaths (TAVR: 13.7 percent vs SAVR: 15.1 percent; RR, 0.86; 0.67–1.10; p=0.22) and cardiovascular mortality rates (8.87 percent vs 10.08 percent; RR, 0.88; 0.73–1.06; p=0.17). The incidences of stroke (RR, 0.90; 0.73–1.10; p=0.31) and myocardial infarction (RR, 0.99; 0.70–1.39; p=0.93) were also comparable between the interventions.

For the meta-analysis, the databases of PubMed, CENTRAL and EBSCO were searched for randomized controlled trials of patients with severe aortic valve stenosis at low-to-intermediate surgical risk. For inclusion, trials should have compared the safety and clinical outcomes between TAVR and SAVR.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Tristan Manalac, 11 Jan 2019
Less than 15 percent of Singaporean adolescents get the recommended 8–10 hours of sleep on a school night, reports a recent study, noting that such short sleep duration is linked to symptoms of depression, overweight or obesity, and poorer self-rated health.
04 Jan 2019
Obstructive sleep apnoea may increase the risk of male-pattern baldness in men with a family history of hair loss, and this association appears to be mediated by low serum transferrin saturation levels related to hypoxia, a study suggests.
6 days ago
Airway type 2 inflammation remains persistent in many asthmatics on inhaled corticosteroids, a new study has shown. These patients tend to be older and have a more severe disease.